Genmab A/S is a solid buy with undervalued stock, robust royalties, and blockbuster ADC potential. Click for my look at GMAB ...

Against a backdrop of rising costs, workforce shortages and fragmented care, the Oracle Health and Life Sciences Summit convened leaders who are tackling these challenges head-on. Among the most ...

The commercial success of existing lipid-lowering medications highlights the enormous market potential for effective ...

Offshore structures constantly face threats from severe environmental forces—including strong winds, large waves, and earthquakes. These forces seriously ...

In the rapidly evolving field of computational intelligence, there is a pressing demand for advanced tools and algorithms that can significantly transform ...